China has agreed to finance a feasibility study for a cross-border railway with Nepal under the trans-Himalayan multi-dimensional connectivity network.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.